Accelerating images to intelligence.
AI-powered biomarker quantification for cancer pathology. Faster, more consistent reads, with the expert always in control.
Cancer diagnosis capacity is running out.
The need isn’t.
The WHO projects a global shortfall of health workers, with pathology among the hardest hit.
A June 2026 Lancet Oncology Commission report ties this to deficits in the oncology workforce, with pathology and radiology the primary diagnostic choke points.
In an ASCP survey, most pathology professionals saw AI as key to relieving overloaded teams.
Patented, clinically validated, and deploying today.
Granted, defensible IP.
Quantified from any microscope.
Commercial pathway, live today.
Strong inter-rater agreement, presented at the American Society of Cytopathology (ASC).
Intelligent automation, expert-reviewed.
MedMorphIQ pairs AI auto-counting with expert review to deliver clinical-grade, reproducible biomarker results and publication-ready reports, straight into your existing workflow.
Built for how labs actually work.
Any microscope
No whole-slide scanner and no new hardware to buy.
Runs locally
Analysis runs on your own machine, your data stays with you.
Patient-ready reports
Clean, shareable reports for your practice and your patients.
Human in the loop
Every result is expert-reviewed before it’s used.
Accurate. Consistent. Fast.
Matches manual counting
Matches the gold standard of manual counting. In validation, results closely mirrored expert manual reads.
Same result every time
Reproducible results on every run, removing the inter-observer variability that creeps in between analysts and reads.
Results in seconds
Quantify a field of view in seconds and move on, accelerating turnaround without compromising on quality.
From raw slide to expert-level result.
Drag the handle from left to right, raw field of view on the left, AI-quantified read on the right.
Let’s talk.
We’d love to hear from labs, pathology practices, partners, and investors.
✉ rishik@medmorphiq.com